Caron A. Jacobson - Publications, H-index & Citations

Caron A. Jacobson

harvard university medical affiliates

59H指数

577论文数

2.3W被引数

收录论文 99

发表时间

Axicabtagene ciloleucel demonstrates superior outcomes over historically available treatments in relapsed/refractory follicular lymphoma: 5-year comparative analysis between ZUMA-5 and SCHOLAR-5 Axicabtagene ciloleucel 在复发/难治性滤泡性淋巴瘤中显示出优于历史可用治疗的疗效：ZUMA-5 与 SCHOLAR-5 的5年比较分析

LEUKEMIA & LYMPHOMA

IF2.2

2025-12-01

PREAI

Gribben, John G.; Palomba, M. Lia; Limbrick-Oldfield, Eve; Palivela, Madhu; Kanters, Steve; Stilla, Alana M.; Jacobson, Caron A.; Neelapu, Sattva S.; Nikolajeva, Olga; Yan, Jiali H.; Ray, Markqayne D.; Ghione, Paola

Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies 关于未来早期CAR T疗法研究中定义嵌合抗原受体T细胞（CAR T）剂量限制性毒性（DLTs）的建议

Transplantation and Cellular Therapy

IF4.4

2025-11-07

PREAI

Frederick L. Locke; Sarah Nikiforow; Matthew J. Frigault; David G. Maloney; Marco Davila; David B. Miklos; Yi Lin; Judy Vong; Nirav N. Shah; Sattva S. Neelapu; John Welch; Eric Ng; Caron Jacobson; Marcela V. Maus

A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma 同步系统性及中枢神经系统弥漫大B细胞淋巴瘤的治疗与预后回顾性研究

Blood Advances

IF7.1

2025-11-01

OAAI

J. Erika Haydu; Robert A. Redd; Matthew M. Lei; Ephraim P. Hochberg; Jeffrey A. Barnes; Philippe Armand; Jacob D. Soumerai; April F. Eichler; Eric D. Jacobsen; Justin T. Jordan; Caron A. Jacobson; Ann S. LaCasce; Isabel Arrillaga-Romany; J.R. McFaline-Figueroa; Scott R. Plotkin; Ronald W. Takvorian; Ugonma N. Chukwueke; Jennifer L. Crombie; P. Connor Johnson; Philipp Karschnia; Jorg M. Dietrich; Lakshmi Nayak; Jeremy S. Abramson

Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapy 心血管并发症及其与接受嵌合抗原受体T细胞疗法的多发性骨髓瘤患者短期和长期预后的关联

British Journal of Haematology

IF3.8

2025-10-19

PREAI

Osnat Itzhaki Ben Zadok; Panagiotis Simitsis; Caron Jacobson; Omar Nadeem; Matthew J. Frigault; Noopur Raje; Caitlyn Duffy; Patrick Costello; Jamie Dela Cruz; Andrew Looka; Anju Nohria

A clonally expanded nodal T-cell population diagnosed as T-cell lymphoma after CAR-T therapy CAR-T治疗后被诊断为T细胞淋巴瘤的克隆性扩增的淋巴结T细胞群体

Nature Communications

IF15.7

2025-08-12

OAAI

Katie Maurer; Jackson A. Weir; Adi Nagler; Nicholas J. Haradhvala; Hariharan Bharadwaj; Jacob Shapiro; Somkene Alakwe; Vipin Kumar; Brianna Waller; Mikaela McDonough; Jamie Dela Cruz; Loida Luna; Emma Lin; Linsey Gong; Qiyu Gong; Mehdi Borji; Phillip D. Michaels; Jacob P. Laubach; Geraldine Pinkus; Gad Getz; Catherine J. Wu; Fei Chen; Caron Jacobson

Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis CAR T细胞疗法后套细胞淋巴瘤疾病进展的治疗与结局：一项多中心分析

Blood Advances

IF7.1

2025-08-07

OAAI

Zachary D. Epstein-Peterson; Anath C. Lionel; Ashlee Joseph; Esther Drill; Suheil Albert Atallah-Yunes; Taylor R. Brooks; Elise A. Chong; Emeline R. Chong; Jamie Dela Cruz; Matthew J. Frank; Andrew Ip; Madiha Iqbal; Caron A. Jacobson; Manali K. Kamdar; Reem Karmali; Ofrat Beyar-Katz; Kami J. Maddocks; Matthew J. Matasar; Daniel McLoughlin; Reid W. Merryman

Measurable Residual Disease Detection after CAR-T May Predict Response in Patients with Large B-cell Lymphoma CAR-T治疗后微小残留病检测可预测大B细胞淋巴瘤患者的治疗反应

Blood Advances

IF7.1

2025-07-28

OAAI

Nira Krasnow; Katie Maurer; Catherine Song; Justin Rhoades; Kan Xiong; Andjela Crnjac; Timothy Blewett; Lily Gao; Heather Jacene; Reid Merryman; Satyen H. Gohil; Caitlyn Duffy; Liliana I. Guerrero; Jamie Dela Cruz; Mikaela McDonough; Jacquelyn O. Wolff; Robert Redd; Mike Mattie; Brodie Miles; G. Mike Makrigiorgos; Donna S. Neuberg; Scott J. Rodig; Philippe Armand; Caron Jacobson; Viktor A. Adalsteinsson; Catherine J. Wu

Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving Chemoimmunotherapy 老年侵袭性淋巴瘤患者接受化疗免疫疗法后的纵向患者报告结局

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-02-19

PREAI

Johnson, P. Connor; Abramson, Jeremy S.; Lacasce, Ann S.; Armand, Philippe; Barnes, Jeffrey; Merryman, Reid W.; Soumerai, Jacob; Hochberg, Ephraim; Takvorian, Ronald W.; Jacobson, Caron A.; Crombie, Jennifer L.; Fisher, David C.; Schwartz, Joel; Friedman, Robb S.; Stacey, Julia; Yang, Daniel; Coffey, Bridget; Markowitz, Netana; Odejide, Oreofe O.; El-Jawahri, Areej

Long-term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia Ibrutinib联合Umbralisib治疗复发/难治性慢性淋巴细胞白血病的1/1b期研究长期结果

HEMASPHERE

IF14.6

2025-01-15

OAAI

Ryan, Christine E.; Ren, Yue; Tyekucheva, Svitlana; Arnason, Jon E.; Boruchov, Adam M.; Jacobson, Caron A.; Fisher, David C.; Miskin, Hari; Sportelli, Peter; Brown, Jennifer R.

Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma 与新生侵袭性大b细胞淋巴瘤相比，CD19 CAR T在转化的惰性淋巴瘤中的结果

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2024-12-23

OAAI

Thiruvengadam, Swetha Kambhampati; Merryman, Reid; Wang, Yan; Gaulin, Charles; Bezerra, Evandro; Voorhees, Timothy; Seshadri, Madhav R.; Falade, Ayo; Habib, Alma; Ayers, Amy A.; Bailey, Megumi; Brown, Annette; Bailey, Neil; Patel, Krish; Andreadis, Charalambos B.; Kittai, Adam S.; Jacobson, Caron; Palmer, Joycelynne; Forman, Stephen J.; Nastoupil, Loretta; Budde, Lihua E.

Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy 接受嵌合抗原受体T细胞治疗的多发性骨髓瘤和淋巴瘤患者的心血管并发症及其与短期和长期预后的关系

CIRCULATION

IF38.6

2024-11-26

PREAI

Ben Zadok, Osnat Itzhaki; Simitsis, Panagiotis; Jacobson, Caron; Nadeem, Omar; Frigault, Matthew J.; Raje, Noopur; Duffy, Caitlyn; Costello, Patrick; Dela Cruz, Jamie; Looka, Andrew; Nohria, Anju

Long-Term Follow-up of Bendamustine/Rituximab- Rituximab/Cytarabine (BR/RC) Induction Therapy for Previously Untreated Transplant-Eligible Patients with Mantle Cell Lymphoma (MCL)bendamustine/Rituximab- Rituximab/Cytarabine (BR/RC)诱导治疗对先前未治疗的移植符合条件的套细胞淋巴瘤(MCL)患者的长期随访

BLOOD

IF23.1

2024-11-05

PREAI

Ryan, Christine E.; Nizamuddin, Imran A.; Raman, Hari S.; Redd, Robert A.; Watkins, Marcus P.; Lacasce, Ann S.; Fisher, David C.; Kim, Austin I.; Davids, Matthew S.; Jacobson, Caron A.; Odejide, Oreofe O.; Crombie, Jennifer L.; Mehta-Shah, Neha; Cashen, Amanda F.; Ghobadi, Armin; Bartlett, Nancy L.; Jacobsen, Eric D.; Armand, Philippe; Kahl, Brad S.; Merryman, Reid W.

Ipilimumab with and without Nivolumab in Patients with Classic Hodgkin Lymphoma with Progression after PD-1 Blockade 伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1阻断治疗后进展的经典型霍奇金淋巴瘤患者

BLOOD

IF23.1

2024-11-05

PREAI

Merryman, Reid W.; Kline, Justin; Redd, Robert A.; Welsh, Emma L.; Pfaff, Kathleen; Lee, Hannah Juhaie; Mcdonough, Mikaela M.; Ahn, Inhye E.; Brown, Jennifer R.; Crombie, Jennifer L.; Davids, Matthew S.; Fisher, David C.; Jacobsen, Eric D.; Jacobson, Caron A.; Kim, Austin I.; Odejide, Oreofe O.; Parry, Erin M.; Ryan, Christine E.; Shipp, Margaret A.; Armand, Philippe; Rodig, Scott J.; Abramson, Jeremy S.; Lacasce, Ann S.

A Phase 1/2 Study of a ROR1-Targeting CART Cell Therapy (ONCT-808) in Adult Patients with Relapsed/Refractory (R/R) Aggressive B Cell Lymphomas (BCL)一项靶向ROR1的CAR-T细胞疗法（ONCT-808）在复发/难治性（R/R）侵袭性B细胞淋巴瘤（BCL）成人患者中的I/II期研究

BLOOD

IF23.1

2024-11-05

PREAI

Wang, Michael; Johnson, Patrick Connor; Yazji, Salim; Katz, Yisrael; Pietrofeso, Angela; Robinson, James; Mei, Matthew; Frigault, Matthew J.; Breitmeyer, James B.; Jacobson, Caron A.

Treatment Patterns and Outcomes Following Progression of Disease Post-CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter Analysis CAR-T疗法后疾病进展的复发或难治性套细胞淋巴瘤患者的治疗方案与结局：一项多中心分析

BLOOD

IF23.1

2024-11-05

PREAI

Epstein-Peterson, Zachary D.; Lionel, Anath C.; Joseph, Ashlee; Drill, Esther; Atallah-Yunes, Suheil Albert; Brooks, Taylor R.; Chong, Elise A.; Chong, Emeline R.; Dela Cruz, Jamie; Frank, Matthew J.; Ip, Andrew; Iqbal, Madiha; Jacobson, Caron A.; Kamdar, Manali K.; Karmali, Reem; Maddocks, Kami J.; Matasar, Matthew; Merryman, Reid W.; Munoz, Javier; Riedell, Peter A.; Ryan, Christine E.; Salles, Gilles; Sauter, Craig S.; Sawalha, Yazeed; Shouval, Roni; Shukla, Navika; Stanisic, Alexander, V; Therwhanger, Dylan; Van Besien, Herman; Wang, Yucai; Yamshon, Samuel; Zelenetz, Andrew D.; Palomba, Maria Lia; Jain, Preetesh; Kumar, Anita

Tumor Determinants of Response to CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma 弥漫大B细胞淋巴瘤复发或难治性情况下对CAR-T疗法的肿瘤决定因素

BLOOD

IF23.1

2024-11-05

PREAI

Epstein-Peterson, Zachary D.; Ryan, Christine E.; Devlin, Sean M.; Accav, Noa Golan; Avigdor, Abraham; Corona, Magdalena; Danylesko, Ivetta; Dela Cruz, Jamie; Goy, Andre; Jacobson, Caron A.; Katz, Ofrat Beyar; Khatib, Hazim; Kumar, Anita; Leslie, Lori A.; Luna, Alejandro; Marcus, Ronit; Merryman, Reid W.; Perales, Miguel Angel; Rivas-Delgado, Alfredo; Salles, Gilles; Scordo, Michael; Sdayoor, Inbal; Shah, Gunjan L.; Shem-Tov, Noga; Shimoni, Avichai; Vahaba, Nataly; Yerushalmi, Ronit; Zelenetz, Andrew D.; Palomba, Maria Lia; Ip, Andrew; Shouval, Roni

Preliminary Efficacy and Safety of a Phase 1/2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab in Patients with Relapsed/Refractory and Previously Untreated Mantle Cell Lymphoma (MAVO)I期/II期研究中Acalabrutinib、Venetoclax和Obinutuzumab在复发/难治性及初治套细胞淋巴瘤患者中的初步疗效与安全性（MAVO）

BLOOD

IF23.1

2024-11-05

PREAI

Kim, Austin I.; Armand, Philippe; Ryan, Christine E.; Redd, Robert A.; Forsyth, Megan; Mai, Juniper; Pazienza, Samantha; Bresnahan, Caitlin; Kats, Vanessa M.; Abdulkarim, Salah; Waisgerber, Susan M.; Merryman, Reid W.; Fisher, David C.; Ahn, Inhye E.; Crombie, Jennifer L.; Odejide, Oreofe O.; Lacasce, Ann S.; Jacobson, Caron A.; Jacobsen, Eric D.; Parry, Erin M.; Qualls, David A.; Bessnow, Amy C.; Davids, Matthew S.; Brown, Jennifer R.; Arnason, Jon E.; Leukam, Michael; Riedell, Peter A.; Murakami, Mark A.

Impact of Inflammation, Tumor and Product Attributes on Clinical Outcomes in Patients with Relapsed/Refractory Follicular Treated with Ciloleucel 炎症、肿瘤和产品属性对接受Ciloleucel治疗的复发/难治性滤泡性淋巴瘤患者临床结局的影响

BLOOD

IF23.1

2024-11-05

PREAI

Poddar, Soumya; Yan, Jiali; Tiwari, Gayatri; Rinchai, Darawan; Zhang, Wangshu; Budka, Justin; Peng, Weixin; Salunkhe, Shruti; Davis, Madison; Song, Qinghua; Beygi, Sara; Miao, Harry; Mattie, Mike; Shen, Rhine; Jacobson, Caron A.; Bedognetti, Davide; Filosto, Simone; Neelapu, Sattva S.

Real-World Trends of Cytokine Release Syndrome and Neurologic Events, and Pattern of Their Management Among Patients Receiving Axicabtagene Ciloleucel for Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) in the US: A CIBMTR Report 真实世界中，接受阿西美妥昔单抗（axicabtagene ciloleucel）治疗复发或难治性（r/r）大B细胞淋巴瘤（LBCL）的美国患者中，细胞因子释放综合征和神经事件的趋势及其管理模式：一项CIBMTR报告

BLOOD

IF23.1

2024-11-05

PREAI

Wang, Jiasheng; Bhaskar, Shakthi; Adedokun, Babatunde; Oluwole, Olalekan O.; Metheny, Leland; Moskop, Amy; Jacobson, Caron A.; Shouse, Geoffrey; Ahmed, Sairah; Ghobadi, Armin; Dahiya, Saurabh; Yan, Jiali; Hu, Zhen-Huan; Best, Timothy; Kim, Jenny J.; Mirjah, Debbie L.; Pasquini, Marcelo C.; Locke, Frederick L.

Five-Year Outcomes of Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Treated with Brexucabtagene Autoleucel (Brexu-cel) in ZUMA-2 Cohorts 1 and 2 ZUMA-2研究队列1和2中接受Brexucabtagene autoleucel（Brexu-cel）治疗的复发/难治性套细胞淋巴瘤（R/R MCL）患者的五年结局

BLOOD

IF23.1

2024-11-05

PREAI

Wang, Michael; Goy, Andre; Munoz, Javier; Locke, Frederick L.; Jacobson, Caron A.; Hill, Brian T.; Timmerman, John; Flinn, Ian W.; Miklos, David B.; Pagel, John M.; Kersten, Marie Jose; Forcade, Edouard; Topp, Max S.; Houot, Roch; Beitinjaneh, Amer; Zheng, Dan; Chang, Mengru; Shen, Rhine; Zhang, Wangshu; Khalid, Rita Damico; Kloos, Ioana; Reagan, Patrick M.

研究方向